Report outlines steps needed for more responsible antibiotic manufacturing

The article highlights the fact that though the report identifies some positive steps to curb the amount of antibiotic waste released into the environment, more needs to be done. The three key recommendations for companies from the report - to employ effective methods to limit AMR risks; to promote compliance with discharge limits across the antibiotic supply chain; and to disclose actions transparently - are discussed at length.

The article also highlights a key message from the report that companies do need to increase production in order to improve access in low- and middle-income countries but this increase shouldn't contribute to AMR. Marijn Verhoef, Director of Operations and Research is quoted: "Basically, we're saying that as you scale up, do it in a responsible way."

Read the Foundation's report on responsible manufacturing.